Bio­gen opts in­to De­nali Alzheimer's pro­gram tar­get­ing amy­loid be­ta plaque

Bio­gen is tak­ing an­oth­er step in its neu­rode­gen­er­a­tive dis­ease col­lab­o­ra­tion with De­nali Ther­a­peu­tics.

The big biotech an­nounced Wednes­day it is pick­ing up an op­tion for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER